1 – Who can enroll in graduate studies in pharmaceutical sciences?
- MSc: Anyone with a BSc or equivalent (undergraduate degree) in a health-related discipline
- PhD: Anyone with an MSc or equivalent in a health-related discipline
2 – What makes UL programs special?
A quality education
• Personalized programs of study and supervision by internationally renowned researchers working to solve serious health issues
• High-calibre education centred on innovative research combined with unique access to a wide range of exciting courses
• Internationally renowned bilingual research teams and courses taught in English
• Academic support within a people-oriented faculty that cares about its students and has a sizable proportion of international students (38%)
• Instruction and research excellence on par with top-tier schools around the world
A quality environment
• Instruction in multidisciplinary research centres boasting the latest high-tech equipment and ranked among the best in the French-speaking world
• Exposure to the scientific wealth of Université Laval and its world-class affiliated research centres
Affiliated research centres:
CHU de Québec–Université Laval Research Centre
Quebec Heart and Lung Institute Research Centre
Université Laval Primary Healthcare and Services Research Centre (CERSSPL-UL)
CISSS de Chaudière-Appalaches Research Centre
• Université Laval: The biggest French-language university campus in North America offering a multidisciplinary learning environment and a safe campus—a pioneer in sustainable development providing students with a full range of services
3 – What are the research topics, and who is involved?
Graduate studies in pharmaceutical sciences (fundamental, clinical, and population health components) for acquiring and developing cutting-edge knowledge and skills centred on the development, creation, and use of medications and on the identification of new pharmaceutical targets. Get to know our research supervisors:
See the list of our research supervisors and their areas of interest
4 – How much does it cost, and is funding available?
Funding
Université Laval and the Faculty of Pharmacy offer competitive, flexible, and substantial funding so students can focus entirely on their education.
About 40% of enrolled students have scholarships from external organizations. The majority of students receive some kind of funding:
– Direct scholarships
– Scholarships awarded by their supervisor (usually between $15,000 and $25,000 per year)
– Funding in exchange for teaching a course offered by the faculty
Students can also apply for additional support through the Plan for Success offered by the Faculty of Graduate and Postdoctoral Studies (FESP) (MSc: up to $1,500; PhD: up to $10,750)
Click here to learn more about scholarships and financial aid
The cost of tuition and room and board in Québec City
Tuition fees at Université Laval
Québec City offers a high quality of life in a safe environment, all at a relatively low cost.
5 – What are my career prospects?
You’ll develop the professional skills you need to enter the job market. The statistics speak for themselves: 84% of graduates in 2017 found a job in their field.
Graduates of our pharmaceutical sciences programs work in a broad range of fields and settings, including academic research, the pharmaceutical industry, biotechnology, regulatory agencies, public service, business, intellectual property, publishing, journalism, science outreach, and education.
6 – How do I apply for admission?
1 – To apply for admission to a master’s or PhD program in pharmaceutical sciences, future students should first refer to the list of topics to find a research supervisor and then send their potential supervisor the following documents:
- Transcripts
- Letter of interest
- CV
- References
2 – Once they’ve been accepted by a supervisor, future students can apply for admission through the Registrar’s Office.
Master’s in Pharmaceutical Sciences
Master’s in Pharmaceutical Sciences – Pharmacoepidemiology
PhD in Pharmaceutical Sciences
PhD in Pharmaceutical Sciences – Pharmacoepidemiology